About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.

BERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche (ROG.S), opens new tab said on Saturday its experimental multiple sclerosis drug fenebrutinib met the main goal in a late-stage trial in ...

A Huddersfield man's life has been turned upside down after being diagnosed with a rare form of MS that can only be treated in Switzerland. Gareth Kilner, 37, is living with primary progressive ...